Overall, let-7 family members act as tumor suppressors [60,61], but the Lin28/let-7 pathway regulates glucose metabolism in different organs, and the treatment with anti-let7 has been suggested as a potential therapy for T2D [62]. Here, LIN28A is linked to neoplasm.